Pnc Financial Services Group, Inc. Sarepta Therapeutics, Inc. Transaction History

Pnc Financial Services Group, Inc.

  • $190 Billion
  • Q1 2025

A detailed history of Pnc Financial Services Group, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 2,335 shares of SRPT stock, worth $48,894. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,335
Previous 2,891 19.23%
Holding current value
$48,894
Previous $351,000 57.55%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$63.82 - $127.89 $35,483 - $71,106
-556 Reduced 19.23%
2,335 $149,000
Q4 2024

Feb 07, 2025
BUY
$104.54 - $137.94 $15,158 - $20,001
145 Added 5.28%
2,891 $351,000
Q3 2024

Nov 08, 2024
SELL
$124.33 - $156.75 $53,834 - $67,872
-433 Reduced 13.62%
2,746 $342,000
Q2 2024

Aug 09, 2024
BUY
$113.33 - $163.85 $200,934 - $290,506
1,773 Added 126.1%
3,179 $502,000
Q1 2024

May 10, 2024
SELL
$93.7 - $141.53 $17,147 - $25,899
-183 Reduced 11.52%
1,406 $182,000
Q4 2023

Feb 09, 2024
SELL
$67.31 - $124.76 $16,558 - $30,690
-246 Reduced 13.41%
1,589 $153,000
Q3 2023

Nov 13, 2023
SELL
$102.5 - $123.59 $103,730 - $125,073
-1,012 Reduced 35.55%
1,835 $222,000
Q2 2023

Aug 11, 2023
SELL
$106.4 - $157.19 $18,832 - $27,822
-177 Reduced 5.85%
2,847 $326,000
Q1 2023

May 15, 2023
SELL
$117.53 - $155.99 $34,671 - $46,017
-295 Reduced 8.89%
3,024 $416,000
Q4 2022

Feb 10, 2023
SELL
$100.86 - $132.13 $249,124 - $326,361
-2,470 Reduced 42.67%
3,319 $430,000
Q3 2022

Nov 10, 2022
BUY
$75.71 - $119.24 $18,473 - $29,094
244 Added 4.4%
5,789 $639,000
Q2 2022

Aug 12, 2022
SELL
$62.69 - $88.44 $14,982 - $21,137
-239 Reduced 4.13%
5,545 $415,000
Q1 2022

May 12, 2022
BUY
$63.15 - $90.42 $238,896 - $342,058
3,783 Added 189.06%
5,784 $451,000
Q4 2021

Feb 11, 2022
BUY
$77.28 - $99.42 $45,440 - $58,458
588 Added 41.61%
2,001 $180,000
Q3 2021

Nov 05, 2021
BUY
$65.97 - $92.48 $26,058 - $36,529
395 Added 38.8%
1,413 $130,000
Q2 2021

Aug 06, 2021
BUY
$69.38 - $86.75 $3,538 - $4,424
51 Added 5.27%
1,018 $79,000
Q1 2021

May 07, 2021
SELL
$72.25 - $168.95 $35,474 - $82,954
-491 Reduced 33.68%
967 $72,000
Q4 2020

Feb 12, 2021
BUY
$125.56 - $178.74 $47,336 - $67,384
377 Added 34.88%
1,458 $248,000
Q3 2020

Nov 06, 2020
BUY
$127.12 - $172.34 $76,272 - $103,404
600 Added 124.74%
1,081 $151,000
Q2 2020

Aug 07, 2020
SELL
$93.0 - $171.7 $1.73 Million - $3.19 Million
-18,582 Reduced 97.48%
481 $77,000
Q1 2020

May 08, 2020
SELL
$82.38 - $131.64 $34,022 - $54,367
-413 Reduced 2.12%
19,063 $1.86 Million
Q4 2019

Feb 07, 2020
SELL
$76.53 - $135.58 $847,340 - $1.5 Million
-11,072 Reduced 36.24%
19,476 $2.51 Million
Q3 2019

Nov 08, 2019
SELL
$72.81 - $156.91 $730,721 - $1.57 Million
-10,036 Reduced 24.73%
30,548 $2.3 Million
Q2 2019

Aug 09, 2019
SELL
$112.21 - $151.95 $2.99 Million - $4.05 Million
-26,631 Reduced 39.62%
40,584 $0
Q1 2019

May 10, 2019
SELL
$106.67 - $151.68 $1.44 Million - $2.04 Million
-13,458 Reduced 16.68%
67,215 $0
Q4 2018

Feb 08, 2019
SELL
$97.32 - $148.76 $2.37 Million - $3.62 Million
-24,316 Reduced 23.16%
80,673 $8.8 Million
Q3 2018

Nov 09, 2018
SELL
$115.31 - $161.51 $546,454 - $765,395
-4,739 Reduced 4.32%
104,989 $0
Q2 2018

Aug 10, 2018
SELL
$71.74 - $153.69 $520,832 - $1.12 Million
-7,260 Reduced 6.21%
109,728 $0
Q1 2018

May 11, 2018
SELL
$54.02 - $82.27 $935,950 - $1.43 Million
-17,326 Reduced 12.9%
116,988 $0
Q4 2017

Feb 09, 2018
SELL
$47.64 - $56.75 $1.36 Million - $1.62 Million
-28,607 Reduced 17.56%
134,314 $0
Q3 2017

Nov 13, 2017
BUY
$35.73 - $47.15 $5.82 Million - $7.68 Million
162,921
162,921 $0

Others Institutions Holding SRPT

# of Institutions
508
Shares Held
88.9M
Call Options Held
1.39M
Put Options Held
1.13M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $1.83B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email